133 related articles for article (PubMed ID: 27525053)
1. Oxidative Stress as Estimated by Gamma-Glutamyl Transferase Levels Amplifies the Alkaline Phosphatase-Dependent Risk for Mortality in ESKD Patients on Dialysis.
Torino C; Mattace-Raso F; van Saase JL; Postorino M; Tripepi GL; Mallamaci F; Zoccali C; Progredire Study Group
Oxid Med Cell Longev; 2016; 2016():8490643. PubMed ID: 27525053
[TBL] [Abstract][Full Text] [Related]
2. High levels of both serum gamma-glutamyl transferase and alkaline phosphatase are independent preictors of mortality in patients with stage 4-5 chronic kidney disease.
Caravaca-Fontán F; Azevedo L; Bayo MÁ; Gonzales-Candia B; Luna E; Caravaca F
Nefrologia; 2017; 37(3):267-275. PubMed ID: 28648203
[TBL] [Abstract][Full Text] [Related]
3. Serum Gamma-Glutamyltransferase Levels Predict Clinical Outcomes in Hemodialysis Patients.
Park WY; Koh ES; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
PLoS One; 2015; 10(9):e0138159. PubMed ID: 26376075
[TBL] [Abstract][Full Text] [Related]
4. Liver Metabolic Function of Hemodialysis Patients With Surface Antigen-Positive Hepatitis B.
Ismailov H; Hasanova Z
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():66-8. PubMed ID: 26640916
[TBL] [Abstract][Full Text] [Related]
5. A comparison of gamma-glutamyl transferase and alkaline phosphatase as prognostic markers in patients with coronary heart disease.
Ndrepepa G; Holdenrieder S; Cassese S; Fusaro M; Xhepa E; Laugwitz KL; Schunkert H; Kastrati A
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):64-70. PubMed ID: 29126670
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
7. Serum Gamma-Glutamyltransferase Levels Predict Mortality in Patients With Peritoneal Dialysis.
Park WY; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
Medicine (Baltimore); 2015 Aug; 94(31):e1249. PubMed ID: 26252286
[TBL] [Abstract][Full Text] [Related]
8. Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden.
Postorino M; Marino C; Tripepi G; Zoccali C
Kidney Int Suppl; 2008 Dec; (111):S64-6. PubMed ID: 19034330
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study.
Proctor MJ; Talwar D; Balmar SM; O'Reilly DS; Foulis AK; Horgan PG; Morrison DS; McMillan DC
Br J Cancer; 2010 Sep; 103(6):870-6. PubMed ID: 20717110
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.
Haring R; Wallaschofski H; Nauck M; Dörr M; Baumeister SE; Völzke H
Hepatology; 2009 Nov; 50(5):1403-11. PubMed ID: 19670414
[TBL] [Abstract][Full Text] [Related]
11. The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease.
Kim DW; Hwang SY; Nam YJ; Kim D; Shin SJ; Yoon HE
Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1476-1483. PubMed ID: 32586735
[TBL] [Abstract][Full Text] [Related]
12. Increased γ-glutamyl transferase levels predict early mortality in patients with acute pulmonary embolism.
Zorlu A; Yucel H; Bektasoglu G; Turkdogan KA; Eryigit U; Sarikaya S; Ege MR; Tandogan I; Yilmaz MB
Am J Emerg Med; 2012 Jul; 30(6):908-15. PubMed ID: 22386346
[TBL] [Abstract][Full Text] [Related]
13. Snoring amplifies the risk of heart failure and mortality in dialysis patients.
Torino C; Mattace-Raso F; van Saase JL; D'Arrigo G; Tripepi R; Tripepi GL; Postorino M; Mallamaci F; Zoccali C;
Am J Nephrol; 2014; 39(6):536-42. PubMed ID: 24943037
[TBL] [Abstract][Full Text] [Related]
14. Bone alkaline phosphatase and mortality in dialysis patients.
Drechsler C; Verduijn M; Pilz S; Krediet RT; Dekker FW; Wanner C; Ketteler M; Boeschoten EW; Brandenburg V;
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1752-9. PubMed ID: 21597029
[TBL] [Abstract][Full Text] [Related]
15. Gamma-glutamyl transferase variability can predict the development of end-stage of renal disease: a nationwide population-based study.
Lee DY; Han K; Yu JH; Park S; Heo JI; Seo JA; Kim NH; Yoo HJ; Kim SG; Kim SM; Choi KM; Baik SH; Park YG; Kim NH
Sci Rep; 2020 Jul; 10(1):11668. PubMed ID: 32669624
[TBL] [Abstract][Full Text] [Related]
16. γ-Gammaglutamyl transferase predicts all-cause mortality within three-year intervals in patients undergoing peritoneal dialysis.
Chen YB; Zhan XJ; Xiao J; Zhu HM
Ren Fail; 2024 Dec; 46(1):2353339. PubMed ID: 38770975
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk for end-stage kidney disease and death in a large population-based cohort.
Zitt E; Pscheidt C; Concin H; Kramar R; Peter RS; Beyersmann J; Lhotta K; Nagel G
Sci Rep; 2018 May; 8(1):7729. PubMed ID: 29769597
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study between alkaline phosphatase and gamma-glutamyltranspeptidase in the diagnosis of hepatic metastases].
Osanaga E; Larre Borges A; Sanguinetti J; Mancusso G; Lopez A; Larreborges U
J Chir (Paris); 1985 Jan; 122(1):17-20. PubMed ID: 2858490
[TBL] [Abstract][Full Text] [Related]
19. Γ-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men.
Wannamethee SG; Whincup PH; Shaper AG; Lennon L; Sattar N
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):830-5. PubMed ID: 22223732
[TBL] [Abstract][Full Text] [Related]
20. The relationship between gamma-glutamyl transferase levels and chronic kidney disease among Appalachian adults.
Cain LR; Ducatman AM; Shankar A
W V Med J; 2012; 108(1):8-13. PubMed ID: 25134186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
